Company profile
ANTABIO
Developing Tomorrow's Antibacterials
- Industry
- Biotechnology Research
- Employees
- 25
- Headquarters
- Labege
- Founded
- 2009
- Office locations
- 1
ANTABIO company summary
ANTABIO is a company in the Biotechnology Research industry, headquartered in Labege, founded in 2009. On LinkedIn the company has around 25 employees. Its listed specialties include Antibacterial drug discovery, Drug development, Antibiotic Adjuvant.
What technology does ANTABIO use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About ANTABIO
Antabio is a privately held, clinical-stage biopharmaceutical company dedicated to developing novel and highly differentiated antibacterial treatments targeting drug-resistant infections caused by WHO and CDC critical priority pathogens. Guided by scientific excellence and a clear mission, Antabio’s mission is to deliver life-saving therapies that combat antimicrobial resistance (AMR) and help preserve the effectiveness of antibiotics for future generations. Antabio’s lead program, MEM-ANT3310, is a next-generation β-lactam/β-lactamase inhibitor (BL/BLI) combination currently in Phase 1 clinical development. Designed to treat severe hospital infections caused by multidrug-resistant Gram-negative bacteria, MEM-ANT3310 represents a major step forward in addressing one of the most urgent public health challenges of our time.
Specialties
Where is ANTABIO located?
ANTABIO lists 1 location.
Compare companies similar to ANTABIO
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
ANTABIO antabio.com | Biotechnology Research | 25 | 2009 | Labege |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about ANTABIO
What does ANTABIO do?
Antabio is a privately held, clinical-stage biopharmaceutical company dedicated to developing novel and highly differentiated antibacterial treatments targeting drug-resistant infections caused by WHO and CDC critical priority pathogens. Guided by scientific excellence and a clear mission, Antabio’s mission is to deliver life-saving therapies that combat antimicrobial resistance (AMR) and help preserve the effectiveness of antibiotics for future generations. Antabio’s lead program, MEM-ANT3310, is a next-generation β-lactam/β-lactamase inhibitor (BL/BLI) combination currently in Phase 1 clinical development. Designed to treat severe hospital infections caused by multidrug-resistant Gram-negative bacteria, MEM-ANT3310 represents a major step forward in addressing one of the most urgent public health challenges of our time.
How many employees does ANTABIO have?
ANTABIO has around 25 employees on LinkedIn.
Where is ANTABIO headquartered?
ANTABIO is headquartered in Labege.
When was ANTABIO founded?
ANTABIO was founded in 2009.
Build a lead list from companies like ANTABIO
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.